Drug
Clonidine Transdermal System
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Application Site Pruritus | 343 | 155.4 | 186.0 | signal |
| 2 | Application Site Rash | 195 | 145.1 | 160.1 | signal |
| 3 | Application Site Erythema | 301 | 117.1 | 136.9 | signal |
| 4 | Application Site Irritation | 120 | 98.6 | 104.6 | signal |
| 5 | Product Adhesion Issue | 164 | 47.0 | 51.0 | signal |
| 6 | Application Site Pain | 81 | 37.4 | 38.9 | signal |
| 7 | Blood Pressure Increased | 251 | 16.6 | 18.8 | signal |
| 8 | Dermatitis Contact | 16 | 14.3 | 14.4 | signal |
| 9 | Blood Pressure Fluctuation | 30 | 12.6 | 12.8 | signal |
| 10 | Product Packaging Quantity Issue | 11 | 10.2 | 10.3 | signal |
| 11 | Blood Pressure Systolic Increased | 18 | 9.3 | 9.4 | signal |
| 12 | Blood Pressure Abnormal | 17 | 8.7 | 8.8 | signal |
| 13 | Scar | 14 | 8.3 | 8.3 | signal |
| 14 | Sinus Bradycardia | 7 | 7.3 | 7.3 | signal |
| 15 | Drug Effect Decreased | 37 | 6.9 | 7.0 | signal |
| 16 | Hypertension | 143 | 6.8 | 7.3 | signal |
| 17 | Anorexia | 8 | 6.2 | 6.2 | signal |
| 18 | Product Quality Issue | 82 | 6.2 | 6.4 | signal |
| 19 | Blood Pressure Decreased | 35 | 5.3 | 5.4 | signal |
| 20 | Drug Dispensing Error | 8 | 5.2 | 5.2 | signal |
| 21 | Pharmaceutical Product Complaint | 13 | 5.0 | 5.0 | signal |
| 22 | Dermatitis Allergic | 6 | 4.9 | 4.9 | signal |
| 23 | Wrong Technique In Product Usage Process | 95 | 4.8 | 4.9 | signal |
| 24 | Medication Error | 26 | 4.7 | 4.8 | signal |
| 25 | Heart Rate Decreased | 16 | 4.6 | 4.6 | signal |
| 26 | Scab | 5 | 4.5 | 4.5 | signal |
| 27 | Skin Irritation | 20 | 4.4 | 4.4 | signal |
| 28 | Renal Failure Acute | 18 | 4.2 | 4.3 | signal |
| 29 | Heart Rate Irregular | 9 | 4.0 | 4.0 | signal |
| 30 | Hypothermia | 4 | 4.0 | 4.0 | signal |
| 31 | Sedation | 10 | 3.9 | 3.9 | signal |
| 32 | Hypertensive Crisis | 4 | 3.6 | 3.6 | signal |
| 33 | Skin Reaction | 5 | 3.6 | 3.6 | signal |
| 34 | Rebound Effect | 4 | 3.6 | 3.6 | signal |
| 35 | Product Substitution Issue | 17 | 3.0 | 3.0 | signal |
| 36 | Neuroleptic Malignant Syndrome | 3 | 2.6 | 2.6 | no signal |
| 37 | Product Physical Issue | 5 | 2.5 | 2.5 | no signal |
| 38 | Withdrawal Syndrome | 10 | 2.4 | 2.4 | signal |
| 39 | Wrong Technique In Drug Usage Process | 8 | 2.2 | 2.2 | signal |
| 40 | Circumstance Or Information Capable Of Leading To Medication Error | 7 | 2.1 | 2.1 | no signal |
| 41 | Drug Administration Error | 6 | 2.0 | 2.0 | no signal |
| 42 | Incorrect Dose Administered By Device | 4 | 1.6 | 1.6 | no signal |
| 43 | Skin Burning Sensation | 11 | 1.6 | 1.6 | no signal |
| 44 | Completed Suicide | 13 | 1.6 | 1.6 | no signal |
| 45 | Tardive Dyskinesia | 4 | 1.4 | 1.4 | no signal |
| 46 | Extrapyramidal Disorder | 3 | 1.2 | 1.2 | no signal |
| 47 | Incorrect Route Of Drug Administration | 4 | 1.1 | 1.1 | no signal |
| 48 | Drug Withdrawal Syndrome | 7 | 0.8 | 0.8 | no signal |